Medroxyprogesterone Acetate Injectable Suspension, USP - vials and pre- filled syringes

Greenstone LLC

Revision date : 2011-05-02

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

25322-68-3

Name of the chemical

polyethyleneglycol

Concentration

N/A

EC/CAS

9005-65-6

Name of the chemical

polyethyleneglycol sorbitan monooleate

Concentration

N/A

EC/CAS

99-76-3

Name of the chemical

4-hydroxybenzoic acid, methyl ester

Concentration

N/A

EC/CAS

94-13-3

Name of the chemical

Propylparaben; propyl 4-hydroxybenzoate

Concentration

N/A

EC/CAS

7732-18-5

Name of the chemical

Water, distilled, conductivity or of similar purity H2O

Concentration

N/A

EC/CAS

202-785-7

Name of the chemical

4-Hydroxybenzoic acid and its Methyl- and Ethyl-esters, and their salts

Concentration

N/A

EC/CAS

202-307-7

Name of the chemical

Propylparaben; propyl 4-hydroxybenzoate

Concentration

N/A

EC/CAS

231-791-2

Name of the chemical

Water, distilled, conductivity or of similar purity H2O

Concentration

N/A

General Information

Revision date

2011-05-02

Product name

Medroxyprogesterone Acetate Injectable Suspension, USP - vials and pre- filled syringes

Product Synonyms

None

Emergency telephone

(24 hours) 1-800-262-8200

Icons in SDS

Company Information

company name

Greenstone LLC

GHS Information

Signal word

DANGER

Section 2

SECTION 2: Hazards identification

Appearance: White to off-white suspension

Signal word

DANGER

Hazard statements

May damage fertility or the unborn child. Suspected of causing cancer. Known Clinical Effects: Adverse effects associated with therapeutic use of medroxyprogesterone acetate include menstrual irregularities, abdominal pain or discomfort weight changes, dizziness, headache, weakness or fatigue, and nervousness. EU Indication of danger: Toxic to reproduction: Category 1 Carcinogenic: Category 2 EU Hazard Symbols: EU Risk Phrases: R45 - May cause cancer. R60 - May impair fertility. Australian Hazard Classification

Hazardous Ingredients

Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.